Evidence map›Paper›PMID 26996322›Full record

ArticleNature communications2016

Ciliary IFT80 balances canonical versus non-canonical hedgehog signalling for osteoblast differentiation.

Xue Yuan, Jay Cao, Xiaoning He, Rosa Serra, Jun Qu, Xu Cao, Shuying Yang

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 123 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. From mesenchymal niches to engineeredMaterials today. Bio · 2022
    Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Xue YuanDepartment of Oral Biology, School of Dental Medicine, University of Buffalo, The State University of New York, 3435 Main Street, Buffalo, New York 14214, USA.
Jay CaoUSDA Grand Forks Human Nutrition Research Center, Grand Forks, North Dakota 58202, USA.
Xiaoning HeDepartment of Oral Biology, School of Dental Medicine, University of Buffalo, The State University of New York, 3435 Main Street, Buffalo, New York 14214, USA.
Rosa SerraDepartment of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.
Jun QuDepartment of Pharmaceutical Sciences, University at Buffalo, The State University of New York, New York 14214, USA.
Xu CaoDepartment of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Shuying YangDepartment of Oral Biology, School of Dental Medicine, University of Buffalo, The State University of New York, 3435 Main Street, Buffalo, New York 14214, USA.
University at Buffalo, State University of New York · USGrand Forks Human Nutrition Research Center · USJohns Hopkins Medicine · USUniversity of Alabama at Birmingham · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Dean G. Tang · 1985 to 2026
$116.6M
Regulation of skeletal development and homeostasis by IFT proteinR01DE023105 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI YANG, SHUYING · 2014 to 2018
$2.0M
Role of RGS12, a Regulator of G protein Signaling, in Bone RemodelingR01AR066101 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI YANG, SHUYING · 2014 to 2018
$1.8M
Function of Regulator of G protein signaling in aging skeletonR01AG048388 · NIA · UNIVERSITY OF PENNSYLVANIA · PI YANG, SHUYING · 2014 to 2018
$1.7M
The role of IFT80 in bone formationR03AR061052 · NIAMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI YANG, SHUYING · 2012 to 2014
$232k
NCI NIH HHS P30 CA016056NCI NIH HHS P30CA016056NIAMS NIH HHS AR066101NIAMS NIH HHS R01 AR066101NIAMS NIH HHS R03 AR061052NIA NIH HHS AG048388NIA NIH HHS R01 AG048388NIDCR NIH HHS DE023105NIDCR NIH HHS R01 DE023105
6 · The paper itself

Abstract

Intraflagellar transport proteins (IFT) are required for hedgehog (Hh) signalling transduction that is essential for bone development, however, how IFT proteins regulate Hh signalling in osteoblasts (OBs) remains unclear. Here we show that deletion of ciliary IFT80 in OB precursor cells (OPC) in mice results in growth retardation and markedly decreased bone mass with impaired OB differentiation. Loss of IFT80 blocks canonical Hh-Gli signalling via disrupting Smo ciliary localization, but elevates non-canonical Hh-Gαi-RhoA-stress fibre signalling by increasing Smo and Gαi binding. Inhibition of RhoA and ROCK activity partially restores osteogenic differentiation of IFT80-deficient OPCs by inhibiting non-canonical Hh-RhoA-Cofilin/MLC2 signalling. Cytochalasin D, an actin destabilizer, dramatically restores OB differentiation of IFT80-deficient OPCs by disrupting actin stress fibres and promoting cilia formation and Hh-Gli signalling. These findings reveal that IFT80 is required for OB differentiation by balancing between canonical Hh-Gli and non-canonical Hh-Gαi-RhoA pathways and highlight IFT80 as a therapeutic target for craniofacial and skeletal abnormalities.

Indexed as

Cell DifferentiationSignal TransductionAnimalsBone Diseases, MetabolicCarrier ProteinsCiliaGene DeletionHedgehog ProteinsMice, KnockoutOrganogenesisOsteoblastsOsteogenesisrhoA GTP-Binding ProteinStem CellsStress FibersCarrier ProteinsHedgehog ProteinsIFT80 protein, mouserhoA GTP-Binding Protein

Identifiers

PMID26996322
PMCPMC4802171
OpenAlexW2311799170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.